Vivani Medical, Inc.
VANI
$1.22
-$0.025-2.02%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 4.79% | -10.97% | -10.65% | -18.39% | -1.68% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 6.01% | -5.96% | -8.49% | -8.96% | 0.52% |
Operating Income | -6.01% | 5.96% | 8.49% | 8.96% | -0.52% |
Income Before Tax | -5.51% | 6.40% | 8.44% | 12.81% | -29.39% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -5.51% | 6.40% | 8.44% | 12.81% | -29.39% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -5.51% | 6.40% | 8.44% | 12.81% | -29.39% |
EBIT | -6.01% | 5.96% | 8.49% | 8.96% | -0.52% |
EBITDA | -5.95% | 6.25% | 8.76% | 9.23% | -0.65% |
EPS Basic | 4.91% | 15.59% | 15.22% | 22.64% | -16.59% |
Normalized Basic EPS | 4.93% | 15.62% | 15.26% | 16.38% | 13.47% |
EPS Diluted | 4.91% | 15.59% | 15.22% | 22.64% | -16.59% |
Normalized Diluted EPS | 4.93% | 15.62% | 15.26% | 16.38% | 13.16% |
Average Basic Shares Outstanding | 10.55% | 10.77% | 8.10% | 11.07% | 16.58% |
Average Diluted Shares Outstanding | 10.55% | 10.77% | 8.10% | 11.07% | 16.25% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |